APO-PRAMIPEXOLE pramipexole dihydrochloride 1 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride 1 mg tablets blister pack

apotex pty ltd - pramipexole dihydrochloride monohydrate -

APO-PRAMIPEXOLE pramipexole dihydrochloride 0.25 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride 0.25 mg tablets blister pack

apotex pty ltd - pramipexole dihydrochloride monohydrate -

APO-PRAMIPEXOLE pramipexole dihydrochloride 0.125 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride 0.125 mg tablets blister pack

apotex pty ltd - pramipexole dihydrochloride monohydrate -

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 3 mg - tablet, modified release - excipient ingredients: silicon dioxide; calcium hydrogen phosphate; hypromellose; magnesium stearate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 3.75 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate; hypromellose; silicon dioxide; magnesium stearate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 0.375 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 0.375 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.375 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate; hypromellose; magnesium stearate; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.75 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; calcium hydrogen phosphate; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 4.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; magnesium stearate; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 2.25 mg - tablet, modified release - excipient ingredients: silicon dioxide; magnesium stearate; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; hypromellose; magnesium stearate; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.